Successful combined anti‐CD19 immunotherapy of relapsed acute lymphoblastic leukaemia in a child with Nijmegen breakage syndrome

Documenti analoghi

• CD19‐CAR T‐cell therapy with sorafenib in post‐HSCT relapse of mixed phenotype acute leukaemia (MPAL) with phenotypic myeloid to lymphoid lineage switch—A case report and review of the literature
  di: A. Oszer, et al.
  Pubblicazione: (2024)
• Hypomethylating agent and venetoclax are effective salvage therapies in relapsed/refractory early T‐cell precursor acute lymphoblastic leukaemia
  di: Vaibhav Agrawal, et al.
  Pubblicazione: (2025)
• Central nervous system involvement and relapse in adult acute lymphoblastic leukaemia—a population‐based analysis in 2007–2022
  di: Erik Boberg, et al.
  Pubblicazione: (2026)
• Infant acute lymphoblastic leukaemia—Progress from worldwide clinical efforts
  di: Neil Barrett, et al.
  Pubblicazione: (2025)
• HOPX as a tumour‐suppressive protein in T‐cell acute lymphoblastic leukaemia
  di: Chien‐Chin Lin, et al.
  Pubblicazione: (2024)